NecstGen is hosting a CGT Circle event on October 16th at our site in Leiden supporting The CGT Circle‘s mission to harness the collective power and experience of women in the field of Cell and Gene Therapy.
Join for an afternoon with brilliant speakers sharing insights on their career, lessons learned, and valuable advice and connect over networking drinks.
Don’t miss out on this event and use the registration link below to sign up.
NecstGen and Digi.Bio join forces to advance cell and gene therapy testing, leveraging lab-on-a-chip technology to improve precision, scalability, and efficiency.
Chimeric Antigen Receptor (CAR) T cell therapy represents a transformative approach in medicine, particularly in oncology. This method offers personalised treatment by harnessing a patient's immune system to target and eliminate (cancer) cells. These novel therapies...
Shifting from traditional, ad hoc methodologies to a structured, data-based development approach to create a scalable, GMP-ready process.
Explore available CAR therapies, differentiation, development challenges, and lessons learned from our expert scientist.
NecstGen is a non-profit CDMO and Centre of Excellence for Cell and Gene Therapy located in a purpose-built GMP facility in Leiden, The Netherlands. Dedicated to the field of Cell and Gene Therapies, we provide expertise and capacity.
